Fasinumab
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Lua error in Module:Infobox at line 166: malformed pattern (missing ']').
Fasinumab is a human monoclonal antibody designed for the treatment of pain.[1] Fasinumab for acute sciatic pain[2]
This drug was developed by Regeneron Pharmaceuticals.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Fasinumab, American Medical Association.
- ↑ http://www.dovepress.com/fasinumab-regn475-an-antinerve-growth-factor-monoclonal-antibody-for-t-peer-reviewed-article-JPR
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems
|
|||||||||
---|---|---|---|---|---|---|---|---|---|
Bone ("-os-", "-s(o)-") |
|
||||||||
Musculoskeletal ("-mul-") |
|
||||||||
Circulatory ("-c(i[r])-") |
|
||||||||
Neurologic ("-ne(u)(r)-") |
|
||||||||
Angiogenesis inhibitor ("-anibi-") |
|
||||||||
|
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://infogalactic.com/w/index.php?title=Fasinumab&oldid=722782596"
Categories:
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Monoclonal antibody stubs
- Monoclonal antibodies
Hidden categories: